BLCO
Price
$16.70
Change
-$0.15 (-0.89%)
Updated
Jan 30 closing price
Capitalization
5.8B
17 days until earnings call
Intraday BUY SELL Signals
SOLV
Price
$76.97
Change
+$0.45 (+0.59%)
Updated
Jan 30 closing price
Capitalization
13.35B
25 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BLCO vs SOLV

Header iconBLCO vs SOLV Comparison
Open Charts BLCO vs SOLVBanner chart's image
Bausch + Lomb
Price$16.70
Change-$0.15 (-0.89%)
Volume$194.71K
Capitalization5.8B
Solventum
Price$76.97
Change+$0.45 (+0.59%)
Volume$1.35M
Capitalization13.35B
BLCO vs SOLV Comparison Chart in %
BLCO
Daily Signal:
Gain/Loss:
SOLV
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BLCO vs. SOLV commentary
Feb 01, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLCO is a Hold and SOLV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 01, 2026
Stock price -- (BLCO: $16.70 vs. SOLV: $76.97)
Brand notoriety: BLCO and SOLV are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BLCO: 58% vs. SOLV: 134%
Market capitalization -- BLCO: $5.8B vs. SOLV: $13.35B
BLCO [@Pharmaceuticals: Other] is valued at $5.8B. SOLV’s [@Pharmaceuticals: Other] market capitalization is $13.35B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $178.74B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.52B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLCO’s FA Score shows that 1 FA rating(s) are green whileSOLV’s FA Score has 1 green FA rating(s).

  • BLCO’s FA Score: 1 green, 4 red.
  • SOLV’s FA Score: 1 green, 4 red.
According to our system of comparison, both BLCO and SOLV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLCO’s TA Score shows that 3 TA indicator(s) are bullish while SOLV’s TA Score has 2 bullish TA indicator(s).

  • BLCO’s TA Score: 3 bullish, 4 bearish.
  • SOLV’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, BLCO is a better buy in the short-term than SOLV.

Price Growth

BLCO (@Pharmaceuticals: Other) experienced а -1.65% price change this week, while SOLV (@Pharmaceuticals: Other) price change was -2.46% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.17%. For the same industry, the average monthly price growth was +1.50%, and the average quarterly price growth was +26.40%.

Reported Earning Dates

BLCO is expected to report earnings on Feb 18, 2026.

SOLV is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-2.17% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SOLV($13.4B) has a higher market cap than BLCO($5.8B). BLCO YTD gains are higher at: -2.225 vs. SOLV (-2.865). SOLV has higher annual earnings (EBITDA): 2.59B vs. BLCO (509M). SOLV has more cash in the bank: 1.64B vs. BLCO (310M). BLCO (4.95B) and SOLV (5.14B) have identical debt. SOLV has higher revenues than BLCO: SOLV (8.4B) vs BLCO (4.98B).
BLCOSOLVBLCO / SOLV
Capitalization5.8B13.4B43%
EBITDA509M2.59B20%
Gain YTD-2.225-2.86578%
P/E RatioN/A8.84-
Revenue4.98B8.4B59%
Total Cash310M1.64B19%
Total Debt4.95B5.14B96%
TECHNICAL ANALYSIS
Technical Analysis
BLCOSOLV
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
45%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
68%
Momentum
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
59%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
56%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
62%
Advances
ODDS (%)
Bullish Trend 26 days ago
68%
Bullish Trend 18 days ago
63%
Declines
ODDS (%)
Bearish Trend 5 days ago
69%
Bearish Trend 4 days ago
55%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
62%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
BLCO
Daily Signal:
Gain/Loss:
SOLV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDDLX8.800.03
+0.34%
MassMutual Diversified Value Adm
MLPRX4.94-0.03
-0.60%
Invesco SteelPath MLP Income C
RLNCX50.99-0.46
-0.89%
Russell Inv International Devd Mkts C
AEGFX63.46-1.02
-1.58%
American Funds EUPAC F1
MSIWX17.31-0.43
-2.42%
Morgan Stanley Inst EMkts Ldrs IR

BLCO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLCO has been loosely correlated with RMD. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BLCO jumps, then RMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLCO
1D Price
Change %
BLCO100%
-0.89%
RMD - BLCO
46%
Loosely correlated
+0.27%
XRAY - BLCO
45%
Loosely correlated
+1.63%
CRL - BLCO
45%
Loosely correlated
-0.57%
SOLV - BLCO
45%
Loosely correlated
+0.59%
MTD - BLCO
44%
Loosely correlated
-1.40%
More

SOLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLV has been loosely correlated with NVST. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLV jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLV
1D Price
Change %
SOLV100%
+0.59%
NVST - SOLV
53%
Loosely correlated
+0.34%
XRAY - SOLV
53%
Loosely correlated
+1.63%
RMD - SOLV
52%
Loosely correlated
+0.27%
ALC - SOLV
47%
Loosely correlated
-0.21%
BAX - SOLV
46%
Loosely correlated
+1.72%
More